» Articles » PMID: 20558036

Study Design Attributes Influenced Patients' Willingness to Participate In clinical Research: a Randomized Vignette-based Study

Overview
Publisher Elsevier
Specialty Public Health
Date 2010 Jun 19
PMID 20558036
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To identify characteristics of clinical research projects that influence patients' willingness to participate in research.

Study Design And Setting: We surveyed all patients discharged during 1 month from a Swiss public teaching hospital. We described four hypothetical studies and asked patients whether they would agree to participate. We randomly manipulated three study attributes in each vignette, using a factorial design.

Results: All studies were not equally acceptable to the 1,277 respondents. A higher willingness to participate was found when a new drug had no side effects, no additional visit was required, balanced information was given, results were in the public domain, and the project was approved by a research ethics committee. In contrast, destruction of blood samples at the end of the project, use of placebo controls, and random allocation to study arms were associated with a lower likelihood of participation. The origin of funds, financial reward, the need to complete a questionnaire, and clinical vs. economic purpose of the study did not influence willingness to participate.

Conclusion: Patients valued safety, convenience, oversight, and open communication in research. However, they were put off by some aspects that are valued by health care professionals. Educating the public about research methods may improve participation.

Citing Articles

Prospective Preference Assessment of a Pharmacological Clinical Trial to Alter the Progression of Posttraumatic Osteoarthritis After ACL Reconstruction.

Yang C, Katz J, Selzer F, Conley C, Lemaster N, Stone A Orthop J Sports Med. 2025; 13(3):23259671241311906.

PMID: 40078595 PMC: 11898237. DOI: 10.1177/23259671241311906.


The Quality of Life after Endometrial Cancer Study: Baseline Characteristics and Patient-Reported Outcomes.

Warring S, Yost K, Cheville A, Dowdy S, Faubion S, Kumar A Curr Oncol. 2024; 31(9):5557-5572.

PMID: 39330040 PMC: 11431380. DOI: 10.3390/curroncol31090412.


Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU): Trial Satisfaction and Attitudes towards Future Clinical Trials.

Liu H, Li J, Ziegemeier E, Adams S, McDade E, Clifford D J Prev Alzheimers Dis. 2024; 11(3):558-566.

PMID: 38706272 PMC: 11364440. DOI: 10.14283/jpad.2024.61.


Recruitment to a trial of antipsychotic reduction: impact of an acceptability study.

Ramsay G, Haime Z, Crellin N, Stansfeld J, Priebe S, Long M BMC Med Res Methodol. 2023; 23(1):78.

PMID: 36991350 PMC: 10053425. DOI: 10.1186/s12874-023-01881-0.


How do study design features and participant characteristics influence willingness to participate in clinical trials? Results from a choice experiment.

Thomas C, Mulnick S, Krucien N, Marsh K BMC Med Res Methodol. 2022; 22(1):323.

PMID: 36526978 PMC: 9756590. DOI: 10.1186/s12874-022-01803-6.